IFNGR1 and neoplasm: Next, to determine how responsiveness to IFNγ affects tumor growth and response to checkpoint inhibitors, Ifngr1 was silenced in CMT167 cells using two separate shRNAs against murine Ifngr1 and a nontargeting control vector.